NCT04485013 2026-02-18TTX-080 HLA-G Antagonist in Subjects With Advanced CancersTizona Therapeutics, IncPhase 1 Recruiting240 enrolled
NCT07341737 2026-01-15SL-28 for Advanced Solid TumoursSecond Life TherapeuticsPhase 1/2 Not yet recruiting60 enrolled
NCT05194735 2025-11-10Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsAlaunos TherapeuticsPhase 1/2 Terminated8 enrolled 12 charts
NCT05292859 2025-07-30Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRsAlaunos TherapeuticsCompleted7 enrolled
NCT06299163 2025-07-23NM32-2668 in Adult Patients With Selected Advanced Solid TumorsNumab Therapeutics AGPhase 1 Terminated11 enrolled
NCT04691375 2024-03-22A Study of PY314 in Subjects With Advanced Solid TumorsIkena OncologyPhase 1 Terminated86 enrolled
NCT05498597 2023-10-19AMT-151 in Patients With Selected Advanced Solid TumoursMultitude Therapeutics Inc.Phase 1 Unknown30 enrolled
NCT00101972 2022-02-22RAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaMacroGenicsPhase 1 Completed53 enrolled